NRX Pharmaceuticals, Inc. Share Price
NRXPNRX Pharmaceuticals, Inc. Stock Performance
Open $2.97 | Prev. Close $2.90 | Circuit Range N/A |
Day Range $2.88 - $3.07 | Year Range $1.64 - $3.83 | Volume 26,733 |
Average Traded $3.00 |
NRX Pharmaceuticals, Inc. Share Price Chart
About NRX Pharmaceuticals, Inc.
NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain. Its lead drug candidates include NRX-101, an oral, fixed dosed combination of D-cycloserine and lurasidone for suicidal treatment-resistant bipolar depression in patients with sub-acute suicidal ideation and behavior in phase 2 trial; and NRX-100, a preservative-free formulation of ketamine for intravenous infusion and for the treatment of suicidal depression. The company has a license agreement with Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd.; Apkarian Technologies; development and license agreement with Glytech, LLC; and Sarah Herzog Memorial Hospital. NRx Pharmaceuticals, Inc. was founded in 2015 and is based in Wilmington, Delaware.
NRX Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
29-Apr-26 | $2.95 | $2.92 | -1.02% |
28-Apr-26 | $3.02 | $2.94 | -2.64% |
27-Apr-26 | $3.05 | $3.02 | +2.89% |
24-Apr-26 | $2.87 | $2.94 | +3.70% |
23-Apr-26 | $2.88 | $2.83 | -4.55% |
22-Apr-26 | $2.91 | $2.97 | +0.68% |
21-Apr-26 | $3.18 | $2.95 | -7.52% |